The global burn care centers market size is expected to reach USD 33.03 billion by 2028 according to a new study by Polaris Market Research. The report “Burn Care Centers Market Share, Size, Trends, Industry Analysis Report, By Facility Type (In-house, Standalone), By Treatment Type; By Severity (Minor Burns, Partial Thickness Burns, Full Thickness Burns); By Service Type (Inpatient, Outpatient, Rehabilitation); By Regions; Segment Forecast, 2021 - 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
In 2020, the in-patient type market segment accounted for the largest share of the burn care center industry and is expected to witness the fastest market growth rate over the forecast period, owing to the rise in mass casualties in fire and the continuously rising mortality rate across the globe. Though in-patient stay is not rising at a significant pace in a few of the countries, its high cost of treatment has largely contributed to its high market revenue share in the burn care centers industry. As per the study done by the World Health Organization, in 2018, countries such as China, UK, Bulgaria, Canada, South Korea, U.S., Sweden, Singapore, Hong Kong, and Mexico have witnessed the rise in the incidence of fire-related events.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the following link: https://www.polarismarketresearch.com/industry-analysis/burn-care-centers-market/request-for-sample
Market participants such as The MetroHealth System, Chelsea & Westminster Hospital, Pediatric Burn Care Center, University of Rochester Medical Center, Burn and Reconstructive Centers of America, National Burn Center (India), North Bristol NHS Trust, and University of Washington Regional Burn Center are some of the key players operating in the market for burn care centers.
Companies in the marketplace are launching innovative therapies to address unmet medical needs in severe burn care management. For instance, in May 2019, Israel-based MediWound Ltd signed an exclusive supply agreement with Vericel Corporation to commercialize its product NexoBrid in the U.S.
Product is topically administered biologic to remove scars in people with deep and thick injuries. The product was already approved in the EU and other markets. According to the company’s claims, NexoBrid is considered an excellent strategic fit to capture a larger share in the U.S market for burn care centers.
Polaris Market research has segmented the burn care centers market report on the basis of facility type, treatment type, severity, service type, and region:
Burn Care Centers, Facility Type Outlook (Revenue - USD Million, 2016 - 2028)
Burn Care Centers, Treatment Type Outlook (Revenue - USD Million, 2016 - 2028)
Burn Care Centers, Severity Outlook (Revenue - USD Million, 2016 - 2028)
Burn Care Centers, Service Type Outlook (Revenue - USD Million, 2016 - 2028)
Burn Care Centers, Regional Outlook (Revenue - USD Million, 2016 - 2028)